60
Participants
Start Date
August 31, 2008
Primary Completion Date
June 30, 2011
Study Completion Date
July 31, 2013
Mesenchymal Precursor Cells (MPCs)
25 M allogeneic MPCs by transendocardial injection and mapping.
Mesenchymal Precursor Cells (MPCs)
75 M allogeneic MPCs by transendocardial injection and mapping.
Mesenchymal Precursor Cells (MPCs)
150 M allogeneic MPCs by transendocardial injection
standard-of-care treatment with mock mapping and injection procedures.
Mock
standard-of-care treatment with mock mapping and injection procedures.
Mock
standard-of-care treatment with mock mapping and injection procedures.
Mock
UPMC, Pittsburgh
Texas Heart Institue, Houston
Mercy Gilbert Medical Center, Gilbert
Swedish Heart and Vascular Institute, Seattle
University of California, San Diego, La Jolla
Minneapolis Heart Institute 920 East 28th St, Suite 300, Minneapolis
Lead Sponsor
Mesoblast, Ltd.
INDUSTRY